Letter to the editor regarding Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis
- PMID: 34372884
- PMCID: PMC8352146
- DOI: 10.1186/s13054-021-03702-6
Letter to the editor regarding Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis
Conflict of interest statement
DB receives research support from ALung Technologies. He has been on the medical advisory boards for Baxter, Abiomed, Xenios and Hemovent, and is the President-elect of ELSO. RPB receives research support unrelated to this project from National Institutes of Health’s National Heart, Lung and Blood Institute K12 HL138039 and R01 HL153519 and the National Institute of Child Health and Human Development R01 HD015434. He is the ELSO Registry Chair. EF reports personal fees from ALung Technologies, Baxter, Fresenius Medical Care, Getinge, and MC3 Cardiopulmonary outside the submitted work. He is the Chair of Research Committee for ELSO. GM reports being on the Board of Directors for ELSO. KR reports being on the Scientific Oversight Committee at the ELSO. KS and RRL have no competing interests to report.
Figures

Comment on
-
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1. Crit Care. 2021. PMID: 34127027 Free PMC article.
References
-
- Extracorporeal Life Support Organization: 2021. https://www.elso.org/Registry/FullCOVID19RegistryDashboard.aspx. Accessed 13 July 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical